Plandai Biotechnology Stock Price, News & Analysis
PLPL
OTC
Company Description
Plandai Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutraceutical and pharmaceutical industries. They are developing Phytofare Catechin Complex, a botanical extract from green tea harvested in South Africa, as well as Phytofare Citrus Complex, citrus extract, tomato fruit extract, Artemisia, and cannabis. The company also sells timber and agricultural products from their South African holdings. Based in London, UK.
Stock Performance
$0.0000
+0.00%
+0.00
Last updated: April 27, 2025 at 13:48
- %
Performance 1 year
$4.5M
Market Cap
44.9B
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Plandai Biotechnology.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Plandai Biotechnology (PLPL)?
The current stock price of Plandai Biotechnology (PLPL) is $0.000001 as of April 25, 2025.
What is the market cap of Plandai Biotechnology (PLPL)?
The market cap of Plandai Biotechnology (PLPL) is approximately 4.5M.
What is Plandai Biotechnology, Inc. focused on?
Plandai focuses on producing proprietary botanical extracts for the nutraceutical and pharmaceutical industries.
Where does Plandai source its green tea for Phytofare Catechin Complex?
Plandai sources its green tea from the Senteeko Tea Estate in Mpumalanga, South Africa.
What are some of the botanical extracts Plandai is developing?
Plandai is developing Phytofare Catechin Complex, Phytofare Citrus Complex, tomato fruit extract, Artemisia extract, and cannabis extract.
What other products does Plandai offer besides botanical extracts?
Plandai also produces and sells timber and agricultural products from their farm and tea estate holdings in South Africa.
Where is Plandai Biotechnology, Inc. based?
Plandai Biotechnology, Inc. is based in London, United Kingdom.
What recent announcement did Plandai make?
Plandai announced the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.
Who approved the rescission of the agreement?
The decision to rescind the agreement was approved by both a majority of Plandai shareholders eligible to vote and the board of directors.
What is Plandai exploring after the rescission of the agreement?
Plandai will evaluate its options moving forward and explore alternative opportunities for growth and expansion.
How can I contact Plandai Biotechnology, Inc.?
You can contact Plandai at plandai@protonmail.com.
What is the focus of Plandai Biotechnology, Inc.'s products?
The focus of Plandai's products is on proprietary botanical extracts for the nutraceutical and pharmaceutical industries.